Cohort of Prosthetic Joint Infections
ConditionProsthetic Joint Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGroupe Hospitalier Diaconesses Croix Saint-Simon
About this trial
Management of prosthetic joint infections (PJI) is a challenging task. These infections include different clinical and microbiological settings calling upon various treatment strategies according to infection type (acute or chronic), bone quality, the involved micro-organism and the patient's general condition and willing.
Treatment of PJI combines surgery and prolonged antibiotic therapy. In some patients with a high operative risk prolonged suppressive antibiotic therapy can be used.
Lack of large prospective studies motivated the conception of this cohort with a long term follow up, regardless to PJI management procedures.
Eligibility criteria
Qualifiers
According to musculoskeletal infection society definition: PJI is present when one of the major criteria exists or four out of six minor criteria.
Two positive periprosthetic cultures with phenotypically identical organisms, OR
A sinus tract communicating with the joint, OR
Elevated serum C-reactive protein (CRP) AND erythrocyte sedimentation rate (ESR)
Disqualifiers
Patient who does not meet eligibility criteria.
Patient lawfully deprived of his liberty.
Patient not insured under social security scheme.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov